Last 12 months
Inside the activity.
16 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 2 | 0 |
| Dec 2025 | 3 | 0 |
| Jan 2026 | 3 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 2 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2022 Filed Sep 2, 2022 01:31 UTC |
Williams GreggDirector · 10% owner
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001212 · ownership.xml · derivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 30,187 Underlying: common stock · 30,187 shares Expires 2030-11-09 F1 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. These options are fully vested. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:31 UTC |
Williams GreggDirector · 10% owner
|
OtherCommon Stock Option · Derivative | 30,187 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001212 · ownership.xml · derivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 30,187 Underlying: common stock · 30,187 shares Expires 2029-11-11 F1 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. These options are fully vested. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:31 UTC |
Williams GreggDirector · 10% owner
|
OtherCommon Stock Option · Derivative | 603,731 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001212 · ownership.xml · derivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 603,731 Underlying: common stock · 603,731 shares Expires 2028-08-22 F1 · kind: Represents the replacement option to be issued by Vivian Medical, Inc. (f/k/a Second Sight Medical Products, Inc.) at the effective time of the merger acquisition thereof, pursuant to the terms of the Agreement and Plan of Merger entered into on February 4, 2022. These options are fully vested. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 506,794 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 30 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 506,794 Underlying: common stock · 506,794 shares Expires 2026-12-28 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 506,797 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 29 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 506,797 Underlying: common stock · 506,797 shares Expires 2026-11-29 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 28 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-10-29 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 27 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-09-29 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 26 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-08-27 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 25 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-07-23 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 24 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-06-30 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 23 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-05-24 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 329,891 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 22 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 329,891 Underlying: common stock · 329,891 shares Expires 2026-03-31 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 317,753 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 21 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 317,753 Underlying: common stock · 317,753 shares Expires 2026-02-23 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 109,623 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 20 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 109,623 Underlying: common stock · 109,623 shares Expires 2025-12-08 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 79,505 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 19 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 79,505 Underlying: common stock · 79,505 shares Expires 2025-12-07 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 60,530 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 18 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 60,530 Underlying: common stock · 60,530 shares Expires 2025-10-02 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 127,097 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 17 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 127,097 Underlying: common stock · 127,097 shares Expires 2025-08-31 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 127,097 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 16 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 127,097 Underlying: common stock · 127,097 shares Expires 2025-07-01 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 127,097 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 15 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 127,097 Underlying: common stock · 127,097 shares Expires 2025-06-03 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 14 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2025-04-01 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 13 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2025-01-31 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 12 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2025-01-02 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 11 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2024-12-03 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 10 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2024-11-04 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 9 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2024-10-01 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 8 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2024-09-03 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 7 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2024-07-31 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 6 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2024-07-02 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 476,631 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 5 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 476,631 Underlying: common stock · 476,631 shares Expires 2024-04-15 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 158,875 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 4 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 158,875 Underlying: common stock · 158,875 shares Expires 2024-03-18 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 423,669 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 423,669 Underlying: common stock · 423,669 shares Expires 2023-10-23 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherWarrant · Derivative | 190,650 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · derivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 190,650 Underlying: common stock · 190,650 shares Expires 2025-03-03 F2 · kind: Represents warrants to purchase shares of common stock assumed on the effective date of the acquisition of Nano Precision medical, Inc., consummated on August 30, 2022, pursuant to the Agreement and Plan of Merger dated February 4, 2022. Read SEC document |
| August 30, 2022 Filed Sep 2, 2022 01:30 UTC |
Williams GreggDirector · 10% owner
|
OtherCommon Stock | 7,891,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001753926-22-001210 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,636,814 F1 · kind: Represents shares of common stock issued in the acquisition transaction of Nano Precision Medical Inc. consummated on August 30, 2022. F3 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 9,511,062 shares of common stock and warrants to purchase 7,808,405 shares of common stock owned by GW Trust, (ii) 1,212,856 shares of common stock and warrants to purchase 1,151,012 shares of common stock owned by Williams International Co. LLC (iii) 181,587 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 731,309 shares of common stock and warrants to purchase 287,753 shares of common stock owned by GST. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 01:49 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 100 | $2.00 | $200.00 |
DisclosureSEC source: 0001753926-22-000873 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,237,147 F2 · price: These shares were purchased in a single transaction at $2.00 per share. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased the transaction set forth in this footnote F4 · balance_after: The Gregg G. Williams 2006 Trust ("GW Trust") acquired 100 shares of common stock on June 14, 2022. Mr. Williams is the Trustee of the GW Trust. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,859,893 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 01:49 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 3,700 | $2.00 | $7,400.00 |
DisclosureSEC source: 0001753926-22-000873 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,237,047 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions all at $2.00 per share. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in each transaction set forth in this footnote. F3 · balance_after: The Gregg G. Williams 2006 Trust ("GW Trust") acquired 3,700 shares of common stock on June 13, 2022. Mr. Williams is the Trustee of the GW Trust. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,859,893 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| June 03, 2022 Filed Jun 8, 2022 01:00 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 3,960 | $2.46 | $9,748.33 |
DisclosureSEC source: 0001753926-22-000855 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,233,347 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.355 to $2.25, inclusive. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · balance_after: The Gregg G. Williams 2006 Trust ("GW Trust") acquired 3,960 shares of common stock on June 2, 2022. Mr. Williams is the Trustee of the GW Trust. F3 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,856,093 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 01:36 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 105,162 | $2.34 | $245,721.53 |
DisclosureSEC source: 0001753926-22-000842 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,173,949 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.28 to $2.38, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · balance_after: The Gregg G. Williams 2006 Trust ("GW Trust") acquired 74,870 shares of common stock on May 31, 2022, 132,461 shares of common stock on June 1, 2022 and 105,162 shares of common stock on June 2, 2022. Mr. Williams is a trustee of the GW Trust. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,852,133 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 01:36 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 132,461 | $2.26 | $299,282.38 |
DisclosureSEC source: 0001753926-22-000842 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 11,068,787 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.22 to $2.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,852,133 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| May 31, 2022 Filed Jun 3, 2022 01:36 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 74,870 | $2.33 | $174,447.10 |
DisclosureSEC source: 0001753926-22-000842 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,936,326 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.17 to $2.40, inclusive. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,852,133 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| May 24, 2022 Filed May 26, 2022 01:54 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 55,438 | $1.98 | $110,027.80 |
DisclosureSEC source: 0001753926-22-000800 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,916,894 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.94 to $2.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · balance_after: The Gregg G. Williams 2006 Trust ("GW Trust") acquired 167,160 shares of common stock on May 23, 2022, 55,438 shares of common stock on May 24, 2022. Mr. Williams is a trustee of the GW Trust. F4 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,539,640 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| May 23, 2022 Filed May 26, 2022 01:54 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 167,160 | $1.97 | $328,569.70 |
DisclosureSEC source: 0001753926-22-000800 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,861,456 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.89 to $1.98, inclusive. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,539,640 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| May 20, 2022 Filed May 21, 2022 00:20 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 307,649 | $1.92 | $589,547.78 |
DisclosureSEC source: 0001753926-22-000760 · ownership.xml · nonDerivative · entry 3 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,694,296 F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.805 to $2.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · balance_after: The Gregg G. Williams 2006 Trust ("GW Trust") acquired 387,044 shares of common stock on May 18, 2022, 108,794 shares of common stock on May 19, 2022 and 307,649 shares of common stock on May 20, 2022. Mr. Williams is a trustee of the GW Trust. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,317,042 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| May 19, 2022 Filed May 21, 2022 00:20 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 108,794 | $1.80 | $196,362.29 |
DisclosureSEC source: 0001753926-22-000760 · ownership.xml · nonDerivative · entry 2 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,386,647 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.725 to $1.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,317,042 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| May 18, 2022 Filed May 21, 2022 00:20 UTC |
Williams GreggDirector · 10% owner
|
PurchaseCommon Stock | 387,044 | $1.66 | $642,686.56 |
DisclosureSEC source: 0001753926-22-000760 · ownership.xml · nonDerivative · entry 1 Williams Gregg · CIK 0001624919 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,277,853 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.76, inclusive. The reporting person undertakes to provide to Second Sight Medical Products, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F5 · ownership.nature: After giving effect to the transactions reported on this Form 4, shares beneficially owned by Mr. Williams include (i) 4,317,042 shares of common stock and warrants to purchase 1,713,599 shares of common stock owned by GW Trust, (ii) 3,638,568 shares of common stock and warrants to purchase 3,453,038 shares of common stock owned by Williams International Co. LLC (iii) 544,760 shares of common stock owned by Sam Williams Family Investments LLC and (iv) 2,193,926 shares of common stock and warrants to purchase 863,259 shares of common stock owned by GST. Includes 25,636 shares of common stock issuable to Mr. Williams upon exercise of options. Greg Williams has voting and dispositive power over all of these shares. Read SEC document |
| June 09, 2021 Filed Jun 10, 2021 17:08 UTC |
Popoff Alexandra L.Director
|
GrantCommon Stock | 500 | $6.23 | $3,112.50 |
DisclosureSEC source: 0001209191-21-039403 · doc4.xml · nonDerivative · entry 1 Larson Alexandra L.P. · CIK 0001858534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 F1 · price: Shares acquired in open market transaction. Read SEC document |
| April 13, 2021 Filed Apr 29, 2022 17:43 UTC |
Mendelsohn AaronDirector
|
GiftCommon Stock | 16,724 | $8.39 | $140,314.36 |
DisclosureSEC source: 0001753926-22-000609 · ownership.xml · nonDerivative · entry 1 Mendelsohn Aaron · CIK 0001625195 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Mr. Mendelsohn gifted these shares to Mendelsohn Investment Services LLC, an entity owned by his two adult children. Mr. Mendelsohn has neither an interest in or any voting power in this entity. Read SEC document |
| May 19, 2020 Filed May 20, 2020 00:29 UTC |
McGuire Jonathan WillDirector
|
Disposition to issuerCommon Stock | 3,357 | $5.29 | $17,758.53 |
DisclosureSEC source: 0001209191-20-030770 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,469 F1 · shares: Shares were sold under a rescission offer made to certain ESPP purchasers by the Company. The average price paid for the shares was determined by the original purchase price plus interest until the closing date of the repurchase. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:29 UTC |
RYAN WILLIAM PATRICKChief Operating Officer
|
Disposition to issuerCommon Stock | 1,133 | $5.84 | $6,616.72 |
DisclosureSEC source: 0001209191-20-011662 · doc4.xml · nonDerivative · entry 2 RYAN WILLIAM PATRICK · CIK 0001519007 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,261 F2 · shares: 1,133 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:28 UTC |
McGuire Jonathan WillDirector · Chief Executive Officer
|
SaleCommon Stock | 1,793 | $5.44 | $9,753.92 |
DisclosureSEC source: 0001209191-20-011659 · doc4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,826 F2 · shares: 1,793 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs. Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:27 UTC |
Blake John TChief Financial Officer
|
Disposition to issuerCommon Stock | 809 | $5.44 | $4,400.96 |
DisclosureSEC source: 0001209191-20-011655 · doc4.xml · nonDerivative · entry 2 Blake John T · CIK 0001657162 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,754 F2 · shares: 809 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.